Clinical Trials Logo

Brain Tumor - Metastatic clinical trials

View clinical trials related to Brain Tumor - Metastatic.

Filter by:
  • None
  • Page 1

NCT ID: NCT06106997 Not yet recruiting - Clinical trials for Brain Tumor, Primary

Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

Start date: January 2024
Phase: N/A
Study type: Interventional

The goal of this observational study is to show the feasibility of an MRI-only workflow in brain radiotherapy. The main question it aims to answer is: - Is an MRI-only workflow based on deep learning sCTs feasible in clinical routine? Participants will be treated as in clinical routine, but treatment planning will be based on sCTs, that are generated from MRI images. The dosimetrical equivalence to the standard CT based workflow will be tested at several points in the study.

NCT ID: NCT05831631 Recruiting - Clinical trials for Brain Tumor, Primary

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Start date: August 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to characterize the circulating leukocyte profile and the immune T cells distribution within the tumor in patients with malignant brain tumors and to correlate these findings with the oncological outcome. Participants will be subjected to blood sampling before surgery and for 12 months of follow-up. Additional sampling and analysis will be performed on tumor samples.

NCT ID: NCT04427384 Recruiting - Brain Tumor Clinical Trials

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Start date: September 11, 2020
Phase:
Study type: Observational [Patient Registry]

The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

NCT ID: NCT04314674 Not yet recruiting - Clinical trials for Brain Tumor - Metastatic

Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection

Start date: April 2020
Phase: N/A
Study type: Interventional

Hyperosmotic agents are used to decrease intracranial pressure. The aim of the study is to compare the effects of continuous 3% hypertonic saline (HS), bolus HS and 20% mannitol on intraoperative brain relaxation in patients with raised intracranial pressure during surgery for supratentorial tumors.

NCT ID: NCT04222062 Recruiting - Clinical trials for Brain Tumor - Metastatic

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Start date: November 6, 2020
Phase: Phase 2
Study type: Interventional

This study is being done to see if adding GLIADEL to the site where the tumor was removed works as well as just having the tumor removed with radiation treatment done within six weeks after the surgery to keep the cancer from coming back.

NCT ID: NCT02599142 Completed - Brain Metastases Clinical Trials

Comparing Immobilisation Shells in Cranial Radiotherapy

CORIOLIS
Start date: November 2015
Phase: N/A
Study type: Interventional

Patients having radiotherapy to their head and neck wear an immobilisation shell to prevent patient movement and improve treatment accuracy. These shells tend to cover the face and have the potential to cause anxiety and distress in patients, particularly if they suffer with claustrophobia or a similar fear. The study will use an 'open-face' shell that does not cover the face and compare this with the investigators' current 'closed-face' shell. The investigators will obtain treatment verification x-ray images to assess the daily set-up errors and compare these between the two shell type, and ask both patients and radiographers of their experiences from using the shells. Hypothesis: Open-face immobilisation shells offer equivalent accuracy and efficiency of radiotherapy delivery and are better accepted by patients and radiographers as compared to closed-face immobilisation shells for cranial radiotherapy.

NCT ID: NCT02260531 Completed - Breast Cancer Clinical Trials

Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases

Start date: November 2014
Phase: Phase 2
Study type: Interventional

This research study is evaluating the effectiveness of the drug called cabozantinib (alone or in combination with trastuzumab) as a possible treatment for advanced breast cancer in which the cancer has spread to the brain.